AATMAJ vs GUJTHEM: Stock Comparison
GUJARAT THEMIS BIOSYN is the larger company by market capitalisation. AATMAJ shows lower leverage, while GUJARAT THEMIS BIOSYN shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
AATMAJ leads 4; GUJTHEM leads 7 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | AATMAJ | GUJTHEM |
|---|---|---|
| Sector | — | Healthcare |
| Industry | — | Pharmaceuticals |
Price
| Metric | AATMAJ | GUJTHEM |
|---|---|---|
| Live Price | — | ₹413.7 |
| Day Change | — | -3.21% |
| Volume | — | 4.95 L |
| 52-Week High | — | ₹479 |
| 52-Week Low | — | ₹225.05 |
| Distance from 52W High | — | -13.63% |
Valuation
| Metric | AATMAJ | GUJTHEM |
|---|---|---|
| Market Cap | ₹44 Cr | ₹4,507 Cr |
| P/E Ratio | — | 95.41x |
| P/B Ratio | — | 16.15x |
| EPS | ₹0.32 | ₹4.49 |
| Book Value | ₹22.49 | ₹26.41 |
| Dividend Yield | 0% | 0.16% |
Growth
| Metric | AATMAJ | GUJTHEM |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 17.2% |
| EPS Growth (TTM YoY) | 0% | -9.1% |
| Qtr Sales Growth | 124.95% | 0% |
| Qtr Profit Growth | 39.69% | 0% |
Profitability & Leverage
| Metric | AATMAJ | GUJTHEM |
|---|---|---|
| ROE | 1.4% | 16.22% |
| ROCE | 2.86% | 11.12% |
| Net Margin | 0% | 28.15% |
| Operating Margin | 9.66% | 39.22% |
| Debt to Equity | 0.41x | 0.56x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | AATMAJ | GUJTHEM |
|---|---|---|
| Promoter Holding | 64.33%▲ 0.57 pp | 70.86% |
| FII Holding | 0% | 1.77%▼ 0.03 pp |
| DII Holding | 0% | 1.18% |
| Public Holding | 35.67%▼ 0.57 pp | 26.19%▲ 0.03 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AATMAJ and GUJARAT THEMIS BIOSYN.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.